Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lefusi Health Industry is a leading global provider of sexual wellness products, operating primarily through its Lifestyles Healthcare and Jissbon brands. The company was established as the corporate vehicle for the 2017 acquisition of Ansell's sexual wellness division by a consortium led by Humanwell Healthcare and CITIC Capital. It specializes in the research, development, and manufacturing of condoms, lubricants, and other sexual health devices, utilizing advanced materials like polyisoprene. Lefusi maintains a significant market share in China and internationally, with a robust supply chain and manufacturing facilities located in Southeast Asia. The company is recognized for its innovation in the non-latex condom market through its SKYN brand. As a key subsidiary of Humanwell Healthcare, Lefusi represents a major consolidation of global sexual health assets under Chinese ownership.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lefusi Health Industry.